| Code | 5333C | ||||||||||
| MA number | 68/0298/17-S | ||||||||||
| Product Form: | tbl oro 28x30 mg (blis.PA/Al/PVC/Al/papier/PET-perfor.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 68 - ANTIPSYCHOTICA (NEUROLEPTICA) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PA/Al/PVC/Al/paper/PET | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 09.10.2017 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| SPC: |
SPC_Aripiprazol Mylan_03_2023.pdf
|
| PIL: |
PIL_Aripiprazol Mylan_03_2023.pdf
|
| Safety feature | Yes |
| Data update: | 11.03.2022 |
